Emerging therapies and future directions in CLL--monoclonal antibodies, vaccines and gene therapy.
Binet
J L
JL
Département d'Hématologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines; D002986:Clinical Trials as Topic; D015316:Genetic Therapy; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*
D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines